January 2020: Changes have been made to align this quality standard with the updated NICE guideline on colorectal cancer. Statements 1, 2, 3, 5 and 7 were removed because they are no longer in line with the NICE guideline. Statements 4 and 6 were amended to better reflect the updated guideline. For statement 4, 'risk' of recurrence was replaced with 'stage' and the measures were updated. For statement 6, the wording was changed to be clearer that the statement applies to people with metastatic colorectal cancer in the liver and that review is for suitability for local, rather than surgical, treatment only. New timescales for post-resection colonoscopy were also added to the measures for statement 8. Data sources, links and references were also updated throughout.